A Proinflammatory Endophenotype to Predict NSAID Treatment Response Alzheimer's Disease Clinical Trials

Medicine & Life Sciences

1. Alzheimer Disease 100%
2. Endophenotypes 85%
3. Non-Steroidal Anti-Inflammatory Agents 69%
4. Anti-Inflammatory Agents 39%
5. Cognitive Dysfunction 35%
6. Clinical Trials 34%
7. Therapeutics 15%
8. Inflammation 12%
9. Preliminary Data 11%
10. Proteomics 9%
11. Patient Selection 9%
12. Observational Studies 8%
13. Cardiovascular Diseases 7%
14. Animal Models 7%
15. Biomarkers 6%